Could you explain your rationale for deciding R327 'looks unpromising as a treatment for full blown sepsis'? And how you got that impression from the presentation?
Ann: Investor Presentation - Spark Plus Healthcare Day, page-7
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.005(1.12%) |
Mkt cap ! $104.3M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.5¢ | 44.5¢ | $40.73K | 90.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 83161 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 4716 | 1 |
View Market Depth
| Last trade - 11.08am 05/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |